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Abstract
Background: Access to tertiary care is a problem common to many small states, especially island ones. Although
medical treatment overseas (MTO) may result in cost savings to high income countries, it can be a relatively high
cost for low and middle income source countries. The purpose of this study was to estimate the costs of overseas
medical treatment incurred by the households of medical travelers from Maldives and assess the burden of medical
treatment overseas on the government and on households.
Methods: A survey was conducted of inbound Maldivian medical travelers who traveled during the period
June – December 2013. Participants were stratified by the source of funds used for treatment abroad. Three
hundred and forty four government-subsidized and 471 privately funded Maldivians were interviewed. Self-reported data
on the utilization and expenses incurred during the last visit abroad, including both expenses covered by the
government and borne by the household, were collected using a researcher administered structured questionnaire.
Results: The median per capita total cost of a medical travel episode amounted to $1,470. Forty eight percent of
the cost was spent on travel. Twenty six percent was spent on direct medical costs, which were markedly higher
among patients subsidized by the government than self-funded patients (p = <0.001). The two highest areas of
spending for public funds were neoplasms and diseases of the circulatory system in contrast to diseases of the
musculoskeletal system and nervous system for privately funded patients. Medical treatment overseas imposed a
considerable burden on households as 43 % of the households of medical travelers suffered from catastrophic
health spending. Annually, an estimated $68.9 million was spent to obtain treatment for Maldivians in overseas
health facilities ($204 per capita), representing 4.8 % of the country’s GDP.
Conclusions: Overseas medical treatment represents a substantial economic burden to the Maldives in terms of
lost consumer spending in the local economy and catastrophic health spending by households. Geographical
inequality in access to public funds for MTO and the disproportionate travel cost borne by travelers from rural
areas need to be addressed in the existing Universal Health Care programme to minimize the burden of MTO.
Increased investment to create more capacity in the domestic health infrastructure either through government,
private or by foreign direct investment can help divert the outflow on MTO.
Keywords: Medical treatment overseas, Maldives, Health finance, Medical tourism
* Correspondence: cvirasak@gmail.com
1Epidemiology Unit, Faculty of Medicine, Prince of Songkla University,
Songkla 90110, Thailand
Full list of author information is available at the end of the article
© 2015 Suzana et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Suzana et al. BMC Health Services Research  (2015) 15:418 
DOI 10.1186/s12913-015-1054-2
Background
Globalization and technological advancements have facili-
tated cross country trade in health services, especially in
the mobility of patients to seek medical treatment overseas
(MTO). The medical tourism climate survey of 2013, car-
ried out in 400 health facilities in 77 countries, explains this
phenomena: 60 % of the facilities experienced growth in
the number of international patients in 2012, and 80 %
expected the growth of international patient numbers over
the next 12 months [1]. In Asia, 10 million medical trav-
elers are expected to seek treatment in a few Asian destina-
tions by 2015, doubling the market size of 2011 [2].
Medical treatment overseas, categorized as mode 2 of
the General Agreement on Trade in Services (GATS), is
defined as the supply of health service in the territory of
one member to the consumers of any other member [3].
Organized MTO may result in cost savings to high in-
come countries sending their patients to use services
abroad if the cost is lower than in-country services.
However, it can be a relatively high cost for low and
middle income source countries. Indonesia produced 1
million medical tourists per year in 2007 and 2008,
spending $1 to $1.5 billion abroad [4], while Samoans
spent $2.88 million in 2007, [5] and $1.5 million was
expended on overseas medical providers in 2009 by
Seychelles government [6].
Access to tertiary care is a problem common to many
small states, especially island ones. This study was under-
taken in the Maldives, a small island state situated in the
Indian Ocean. The Maldives is one of the 53 small island
developing states (SIDS) [7], characterized by their narrow
economic base, high production costs, shortage of skilled
labor, heavy dependence on trade and foreign aid. It has an
ethnically homogenous population of 336,224 [8] dispersed
over 198 very small islands. Only 4 islands have a popula-
tion exceeding 5000, and 72 of the islands are populated by
less than 500 people [9]. The Maldivian health system is
customized to fit its unique geography. One primary health
facility is located on each inhabited island. A group of 10
islands on average makes up one atoll, and one atoll hos-
pital is located in each of the 21 atolls providing secondary
health care. Six regional hospitals serve up to 3 to 4 atolls
each. Tertiary care is available in the capital city, Male’. The
Indian medical tourism industry outlook 2015 showed
that Maldives was one of the top importers of health
care from India [10].
The Maldives ranks as a top achiever in health indica-
tors, and has the highest total spending on health in
South East Asia at US$ 558 per capita or 8.5 % of the
GDP in 2011 [11]. Financed through the government
budget, universal health care was introduced in the
Maldives from 2012, with free health care at point of ser-
vice. Government subsidy for MTO is available from
contracted providers only and requires a recommendation
from a public sector specialist doctor. It is limited to direct
medical costs and the airfare of the patient and one care-
taker which are directly paid to airlines and providers by
the government. Expenses not covered by the UHC pro-
gram are paid either through the private insurance market
or from out of pocket. In 2011, the national health ac-
counts of the Maldives estimated household out of
pocket expenditure on MTO at $42.5 million which
was $133 per capita [12]. A survey on Maldivian travel
abroad (MTA 2013) conducted by the Central Bank of
Maldives showed that one out of two Maldivians trav-
eled overseas for various purposes in 2013 and spent
$70 million on medical travel alone [13].
The focus of many of the existing studies on MTO is
on the supply side of the industry. Empirical findings on
the demand for MTO and its effects on the resource
constrained economy are essential to guide better policy
responses. The key features that differentiate the setting
from other countries facing similar problems are its re-
moteness and smallness that limit the opportunities for
economies of scale and competition, which increases the
cost of inputs for the provision of health care. This study
aimed to estimate the current costs of medical treatment
overseas, and assessed the burden of MTO both to the gov-
ernment and households. It contributes to evidence-based
policy responses to address health system issues common
to small and remote countries in a sustainable way.
Methods
Study design
A survey of Maldivians who traveled for medical treatment
during the period June – December 2013 was conducted. A
sample of 342 government subsidized and 418 privately
funded travelers was needed in order to estimate costs with
a precision of at most 5 % difference from the average ac-
tual costs in each group and with the assumption of a 30 %
non-response rate.
Participants
Participants were recruited from three sources and strati-
fied by the type of funds used to pay for treatment abroad.
The first source used was the national database of patients
who had traveled under government financial assistance.
The 2013 database is maintained by the ‘Aasandha’ univer-
sal coverage program covering patients from all the 21 ad-
ministrative atolls of Maldives. Out of 2556 who traveled
during the study period, 344 were randomly selected and a
telephone interview was conducted. This data source con-
sisted of government subsidized travelers only.
Secondly, the three international airports of Maldives lo-
cated in the North, Center and South (Haadhaal atoll,
Kaafu atoll and Seenu atoll respectively) were surveyed to
reach privately funded travelers. All international flights
from all destinations were eligible. As the North and South
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airports operated only one international flight per week, the
Central airport was also surveyed on one random day of
the week. Face to face interviews were conducted with a
consecutive sample of 335 inbound travelers during August
to December 2013.
As a third source, the regional level health facilities
in the aforementioned three atolls were contacted.
With the assistance of the management of the health
facility, privately funded travelers were identified from
lists of referrals made abroad. Telephone interviews
were conducted with 136 available informants. Hence
a total of 471 self-funded patients were interviewed.
A total of 344 government subsidized and 471 pri-
vately funded subjects were interviewed using a com-
mon questionnaire among informants from all the
three data sources to acquire demographic and house-
hold characteristics, utilization and cost data. Overlap-
ping informants were self-identified and repetitive
collection from the same person was avoided. Proxy re-
spondents who were adult relatives or caretakers were
used for elderly, young or very sick patients.
Utilization data on MTO included the country and
hospital of treatment, length of stay for the last visit,
number of accompanying persons, the number of MTO
visits made per year and primary diagnosis for which
treatment was given. Diseases were coded under the 22
major groupings of ICD 10, version 2010 [14]. Ailments
or descriptions that did not fall under any major disease
group were coded under “Factors influencing health status
and contact with health services” (Z00-Z99 of ICD10). This
group (169 observations) was omitted from the analysis of
disease profile following WHO advice not to use this group
for comparisons [15].
Costs of MTO
Cost data was collected on direct medical expenditures, in-
direct expenditures and productivity loss. Direct medical
expenditures included outpatient, inpatient, procedure or
surgery, diagnostics, medicines, room or ward charge, and
other hospital costs. As responses were based on recall, ex-
penditure breakdowns for medical care were not available
in most interviews. Therefore, only the total costs for med-
ical care, available for all the subjects, were used in the ana-
lysis. Indirect expenditures consisted of travel costs, agent
or dealer costs, entertainment costs, food, lodging, and
other costs. Productivity loss was calculated by multiplying
the number of hours lost per day by the number of days
spent overseas and by the income per day as reported by
the participant. All cost categories for the MTO visit were
collected by government and household contributions.
Household expenditures
In addition to MTO costs, monthly out of pocket expend-
iture on health, food and other expenses was collected for
the purpose of calculating the catastrophic expenditure on
health. Catastrophic health expenditure was derived as the
proportion of health spending out of total household ex-
penditure [16]. The incidence of catastrophic payments was
defined as payments in excess of a threshold budget share
and the intensity of catastrophic expenditure was measured
by the payment in excess of the threshold, averaged over all
households exceeding that threshold [16]. The threshold
level was set at 10 % of total household expenditure.
Economic costs
The total economic cost of MTO to the country was calcu-
lated by extrapolating the results from the study samples to
the population estimates of patients and caretakers travel-
ling for medical purposes obtained from secondary data.
Figure 1 shows how the economic costs for MTO were de-
rived. Estimations in block C are the products of estima-
tions in block A and B.
Statistical analysis
The household was the unit of analysis in this study and
the societal perspective was adopted. For analytical pur-
poses, the following continuous variables were collapsed
into categorical data: age, household income, expend-
iture, length of stay and household size. Based on the lo-
cation of the island, the residential island of the patient
was grouped into three regions. Derived variables for the
analysis include catastrophic expenditure and total cost
per traveler per visit. Per capita cost was calculated sep-
arately for the patient and caretaker taking into account
that caretakers do not bear medical costs. Productivity
loss was excluded in the estimation of per capita cost
as it was not a cost but a loss. Frequencies and median
(inter quartile range) were used to describe categorical
and continuous data respectively. Non-parametric tests
for trends were used, as the main outcome measures
(costs) were highly skewed. The standard errors of the es-
timates of economic costs of MTO were derived by the
bootstrap technique which uses a large number of ran-
domly drawn resamples of size ‘n’ from the original sample
to estimate the standard error. The level of significance was
set at p < 0.05, and data analysis was conducted using the
open source R software, version 3.1.0 [17].
Ethical approval
The research was undertaken as a partial fulfillment of
the PhD in epidemiology program of the Prince of
Songkla University (PSU). Hence, ethical approval was
obtained from the Ethics Committee of PSU and the
Research Ethics Committee of the Ministry of Health
of Maldives. Administrative approval was sought from
the Ministry of Transport and Communications to
conduct the airport survey in the three regional air-
ports. The translated version of the questionnaire was
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validated in written format by the Ministry of Educa-
tion of Maldives.
Results
General characteristics
Out of the 815 medical travelers interviewed, 42 % were
subsidized by the government. Females in the adult age
group made up a considerable share of the sample, (Fig. 2).
Table 1 shows the demographic and utilization patterns
among government-subsidized and privately funded pa-
tients. Government subsidized patients were more likely to
reside in the central region, be unemployed and be in the
adult and the elderly age groups (p = <0.001). Subsidized
travelers had an equal distribution by gender, while a
higher proportion of females (66.5 %) were among the
privately funded patients. The two groups did not dif-
fer in their household size (p = 0.3) or income of the
past month (p = 0.5).
Utilization pattern
Indian and Sri Lankan hospitals were the major destina-
tions (98.1 %). Length of stay abroad and reasons for
seeking medical treatment abroad differed significantly
between the two groups. Privately funded patients were
more likely to state that they went in search of better
quality care, while government subsidized patients went
abroad mainly because the required treatment was not
available in the country. Government subsidized patients
stayed overseas longer (p = <0.001). On average a subsi-
dized medical traveler was accompanied by 2.3 persons,
while 3.3 persons accompanied a privately funded patient.
Disease profiles
Table 2 displays the disease groups for which overseas
treatment was most sought by the two groups of medical
travelers. The disease groups differed by age, residential
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Fig. 2 Population pyramid of medical travelers by age and sex
A : Estimations from study results
Mean companions per subsidized patient (k)
Mean companions per privately funded patient (l) 
Mean per capita cost per subsidized patient (m)
Mean per capita cost per subsidized caretaker (n)
Mean per capita cost per privately funded patient (o) C: Estimations of economic costs of MTO
Mean per capita cost per privately funded caretaker (p) Annual cost of subsidized patients: (m)*(u) 
Mean productivity loss (q)
Annual cost of caretakers of subsidized patients: 
(n)*(v) 
Annual cost of privately funded patient: (o)*(x) 
B:Estimations  of patients and caretakers using secondary data and 
study results
Annual cost of caretakers of privately funded 
patient: (p)*(y) 
Total number of Maldivian travelers in 2013 (r) Annual loss in productivity due to MTO: (q)*(z) 
Proportion of medical travelers in 2013 (s) 
Total number of medical travelers in 2013 (t)=(r)*(s) 
Total number of travelers subsidized by 'Aasandha' UHC program (u)
Estimated number of caretaker per subsidized patient using k (v)
Estimated number of privately funded travelers (w) =(t)-(u+v) 
Estimated number of privately funded travelers using l (x)  
Estimated number of caretakers per privately funded patient (y) = (x)*(l) 
Estimated number of patients (z) = (u)+(x) 
Data Sources: Department of Immigration and Emigration, Maldives, 
Maldives Monetary Authority, National Social Protection Agency, Maldives
Fig. 1 Methodology for the extrapolation of Economic costs of MTO using study results and secondary data sources
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Table 1 Demographic characteristics and utilization pattern among two types of medical travelers, 2013
Government subsidized travelers Privately funded travelers Total P value
N (%) N (%) N (%)
Total 344 (42.2) 471 (57.8) 815 (100)
Gender <0.001
Female 169 (49.1) 313 (66.5) 482 (59.1)
Male 175 (50.9) 158 (33.5) 333 (40.9)
Age group <0.001
Children <=9 yrs 53 (15.4) 46 (9.8) 99 (12.1)
Adolescents 10–19 yrs 24 (7) 34 (7.2) 58 (7.1)
Youth 20–29 yrs 30 (8.7) 64 (13.6) 94 (11.5)
Adult 30–59 yrs 163 (47.4) 266 (56.5) 429 (52.6)
Elderly >=60 yrs 74 (21.5) 61 (13) 135 (16.6)
Region of residence <0.001
North 86 (25) 159 (33.8) 245 (30.1)
Central 190 (55.2) 176 (37.4) 366 (44.9)
South 68 (19.8) 136 (28.9) 204 (25)
Occupation of the patient 0.007
Civil servant 52 (15.1) 119 (25.3) 171 (21)
Private sector 35 (10.2) 42 (8.9) 77 (9.4)
Own business 77 (22.4) 88 (18.7) 165 (20.2)
Not employed 136 (39.5) 156 (33.1) 292 (35.8)
Other 44 (12.8) 66 (14) 110 (13.5)
Household size 0.362
Small (<5members) 201 (58.4) 277 (58.8) 478 (58.7)
Medium (6–10 members) 100 (29.1) 149 (31.6) 249 (30.6)
Large (>10 members) 43 (12.5) 45 (9.6) 88 (10.8)
Household income in the past montha 0.499
Poorest 20 % 81 (23.5) 91 (19.3) 172 (21.1)
2nd quintile 65 (18.9) 89 (18.9) 154 (18.9)
3rd quintile 93 (27) 134 (28.5) 227 (27.9)
4th quintile 59 (17.2) 78 (16.6) 137 (16.8)
Richest 20 % 46 (13.4) 79 (16.8) 125 (15.3)
Reason for seeking treatment abroad <0.001
Quality of care 39 (11.3) 185 (39.3) 224 (27.5)
Unavailability of service 234 (68) 126 (26.8) 360 (44.2)
Continuity of care 4 (1.2) 23 (4.9) 27 (3.3)
Better prices 2 (0.6) 19 (4) 21 (2.6)
Long waiting time 8 (2.3) 18 (3.8) 26 (3.2)
Other 57 (16.6) 100 (21.2) 157 (19.3)
Country of treatment 0.087
India 239 (69.5) 305 (64.8) 544 (66.7)
Sri Lanka 105 (30.5) 160 (34) 265 (32.5)
Thailand 0 (0) 5 (1.1) 5 (0.6)
Italy 0 (0) 1 (0.2) 1 (0.1)
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region of the patient and by the type of financial cover-
age (details not displayed). A higher proportion of pa-
tients subsidized by the government were treated for
neoplasms and diseases of the circulatory system (86.3 %
and 57.3 %) in contrast to diseases of the musculoskel-
etal system and nervous system (84.6 % and 66.7 %)
among privately funded travelers. No significant differ-
ence in socio economic status was observed among the
patients suffering from different diseases (p-value = 0.5).
Table 3 shows the major disease groups with the highest
treatment costs. Although the median medical expenditures
were highest for accidents and trauma, the number of cases
in this disease group was small resulting in relatively lower
total costs. Diseases of the circulatory system, neoplasms
and diseases of the nervous system were more common
and hence had the highest proportion of medical expend-
iture among all travelers.
Direct medical expenditures
Table 4 shows the expenditures incurred per visit
overseas for medical treatment. On average, 26 % of the
total cost of treatment abroad was consumed by direct
medical costs, which were markedly higher among pa-
tients funded by the government (p value < 0.001). Other
determinants of high cost included being male and com-
ing from the southern region of the country. Table 5
shows the breakdown of expenditures among the subsi-
dized travelers. The government subsidy for MTO
provided partial coverage for direct medical costs and
travel costs, and accounted for 38 % of the total cost of
the subsidized traveler. The median medical expenditure
of subsidized travelers was on average 67 % higher than
non-subsidized patients.
Indirect expenditures
Non-medical expenditures followed the same pattern
with all expenses being slightly higher among govern-
ment subsidized patients, except for entertainment costs
which were considerably lower (p = <0.001). Patients
from the central region paid comparatively lower travel
costs than patients living in other regions (p = <0.001).
Food and lodging expenses overseas did not differ by
demographic or socio-economic status of the patient.
Travel cost absorbed 48 % of the total cost with no sig-
nificant difference between the groups. Excluding airfare,
expenditure on travel in the home country was on aver-
age $280 compared to $155 in the destination country
(details not shown).
The median per capita total cost of a medical travel
episode was $1,470. Unforeseen expenditures such as
agent fees, foreign exchange costs, and transfer of money
from home country due to unpredicted expenses was
very low due to the small number of patients who in-
curred these expenses. A few patients paid as much as
$1,091 in mortuary fees or purchase of land for burial
and as much as $818 for agent fees during their visit
Table 1 Demographic characteristics and utilization pattern among two types of medical travelers, 2013 (Continued)
Length of stay <0.001
<=1 week 53 (15.4) 100 (21.2) 153 (18.8)
2 weeks 95 (27.6) 180 (38.2) 275 (33.7)
3 weeks 99 (28.8) 116 (24.6) 215 (26.4)
1 month 18 (5.2) 30 (6.4) 48 (5.9)
>1 month 79 (23) 45 (9.6) 124 (15.2)
aHousehold income quintiles are based on the income of the study subjects
Table 2 Distribution of the ten disease groups for which overseas treatment was most sought by type of finance
Disease Groups
(ICD code)
Number Subsidized % Privately funded %
Circulatory (I00–I99) 82 57.3 42.7
Nervous (G00–G99) 69 33.3 66.7
Musculoskeletal (M00–M99) 65 15.4 84.6
Genitourinary (N00–N99) 62 54.8 45.2
Eye (H00–H59) 51 54.9 45.1
Neoplasms (C00–D48) 51 86.3 13.7
Symptoms & signs (R00–R99) 49 28.6 71.4
Injuries (S00–T98) 43 34.9 65.1
Digestive (K00–K93) 35 40.0 60.0
Endocrine (E00–E90) 35 22.9 77.1
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abroad (details not shown). These hidden costs add to
the financial burden of medical treatment overseas.
Catastrophic health expenditure
Health expenditures in the sample population increased
proportionately with increasing total household expendi-
tures (p = <0.001). Figure 3 shows the incidence and in-
tensity of catastrophic payments on health among
medical travelers. 43 % of the households experienced
catastrophic health expenditure, measured by the house-
holds which spent more than 10 % of their monthly ex-
penditure on health care. On average these households
spent 28 % (10 % + 18 % mean positive overshoot) of
their household resources. Between the households with
and without catastrophic expenditure, there was no signifi-
cant difference in household size, household income or the
type of finance that the patient used. However, regional dif-
ferences were observed (Table 6). Most households that
were protected from catastrophic health spending were
located in the Central region, while catastrophic health
spending was highest among households in the South
(p < 0.001). Most common diseases among households
that incurred catastrophic health expenditures were
diseases of the circulatory system (11.1 %) and diseases
of genitourinary system (9.1 %).
Economic costs
Table 7 shows the economic costs of medical treatment
overseas to the Maldives derived from Fig. 1. Through
extrapolation of study results, it was estimated that
$68.9 million was spent in seeking medical treatment
overseas per year by Maldivians which is $204 per
capita. Using 2013 estimates of GDP [18], annual ex-
penditure on MTO by medical travelers represents 4.8 %
of the country’s GDP. As the government subsidy cov-
ered 38 % of the costs borne by subsidized travelers, it is
estimated that the government disburses $5.5million per
year on MTO (details not displayed). This accounts for
8 % of the total expenditures on MTO per year.
Discussion
Using data on both government subsidized patients and
privately funded patients, this study has estimated the
costs of medical treatment overseas to households and
the economy of Maldives. When the health system can-
not offer all services required by the population, it results
Table 3 Selected disease groups with the highest treatment costs
Disease group (ICD 10) No of patients N Median hospitalization price paid $ Total hospitalization cost $
External causes of morbidity & mortality 8 2,420.00 23,977.00
Congenital malformations 9 985.00 12,959.00
Neoplasms 51 890.00 108,769.00
Pregnancy, childbirth & puerperium 3 833.00 2,846.00
Diseases of the blood 7 800.00 29,515.00
Diseases of digestive system 35 700.00 44,004.00
Diseases of the circulatory system 82 691.00 181,215.00
Diseases of genitourinary system 62 603.00 52,151.00
Diseases of nervous system 69 593.00 112,048.00
Diseases of the respiratory system 25 500.00 50,811.00
Table 4 Selected expenditures per visit overseas
Total Government subsidized Privately funded P value
Mean share of cost % Median (IQR)$ Median (IQR) $ Median (IQR) $
No of patients 815 344 471
Direct medical costs 26.0 % 500 (181.5–1150) 825 (300–2085) 300 (147.5–720.5) <0.001
Indirect costs:
Travel 48.0 % 1157 (781–1777.5) 1197 (817.2–1774.2) 1133 (739.5–1804.5) 0.14
Entertainment 8.0 % 100 (0–300) 34.5 (0–200) 142 (0–400) <0.001
Lodging 8.0 % 140 (50–300) 150 (67–300) 127 (47–300) 0.053
Food 6.0 % 105 (50–250) 140 (56–300) 100 (46–210) 0.001
aTotal cost (Patients and caretakers inclusive) 2608 (1749.5–3914) 2984 (1953.2–5041.5) 2355 (1564–3520.5) <0.001
aTotal cost per capita (patient) 1470.8 (888.2–2353.2) 1905.1 (1254.4–3554.4) 1147.3 (709.6–1783) <0.001
Costs that constituted a share of <1 % were omitted, aexcludes productivity loss, IQR: inter-quartile range
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in patients seeking care overseas, often with high medical
bills. It was found that catastrophic health spending was
unavoidable to many medical travelers, despite government
subsidy, and MTO places a heavy financial burden on the
economy of the source country.
Disease profile among travelers in this study differed from
findings in the literature. Diseases of the circulatory system
and nervous system were found to be the most common
among Maldivian patients while medical travelers from
high income countries sought low priority health services.
US patients in Mexico sought dental visits mostly [19],
Canadian patients sought diagnostic procedures [20] and
UK patients went overseas for operations of the skin and its
associated structures [21]. This may be explained by the
heterogeneous nature of the medical tourists and the varia-
tions of health systems across countries.
The choice of Indian and Sri Lankan hospitals sought by
98 % of the travelers can be explained by proximity and fa-
miliarity. Patients from high income countries such as
USA, UK, Canada and middle income countries such as
Nigeria preferred India mainly for affordable prices and to
avoid long waiting times [20, 22]. The fact that patients in
this study sought services that were not available in the
country and for quality of care deviated from the norm
among high and middle income countries. It follows the
characteristics of the poorer economies, where inadequate
health infrastructures exist [23].
This study indicates that the government subsidy is a use-
ful instrument for promoting access to health services not
available in the country. The government has targeted vul-
nerable populations consisting of the elderly, and those
with lengthy, costly diseases, and there were no gender or
socio-economic differences amongst its beneficiaries. The
results add to evidence from Thailand [24], Turkey [25]
and Mexico [26] which showed that universal health care
promotes equality and access to health services.
Government contribution to the MTO cost burden
was found to be low. Public subsidy was estimated to be
Table 5 Breakdown of expenditures among subsidized travelers
(n = 344)
Subsidy $ Out of pocket $
Median (IQR) Median (IQR)
Direct medical costs 500 (106.25–1462.5) 56.5 (0–500)
Indirect costs:
Travel in home country 0 (0–0) 81.5 (8–437.25)
Air fare 336 (200–419.25 ) 400 (336–672)
Travel in destination
country
- 91 (35–200)
Entertainment - 34.5 (0–200)
Lodging - 150 (67–300)
Food - 140 (56–300)
Visa - 0 (0–0)
Foreign exchange costs - 0 (0–0)
Other costs - 0 (0–0)
Productivity loss - 0 (0–202)
Total cost 909(493.25–1805) 1797 (1137.5–3092.25)
Average share of total
cost
38 % 62 %
IQR: inter- quartile range
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Fig. 3 Incidence and intensity of catastrophic health spending among medical travelers
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8 % of the annual expenditure on MTO. The fact that
people have chosen to opt out of the publicly funded
system underlines critical shortfalls in the existing sys-
tem. Geographical inequality in access to public subsidy
for MTO and the availability of private insurance for
MTO may contribute to inequities in access to MTO.
The literature shows that the existence of a parallel pri-
vate health insurance market that enables affordability of
quality care [27] may push people to opt out of the pub-
lic health system. A survey on medical travelers from 27
countries showed that 70 % of the travelers expected the
costs of overseas treatment to be reimbursed by their
health authorities [28]. Increasing accessibility to govern-
ment subsidy for medical travel is important especially
when the local health system is unable to cater to the
needs of the people.
Travel costs absorbed the largest share of total cost of
care overseas and out of pocket expense on travel in the
home country was higher than in the destination countries.
In addition, rural areas were found to bear a disproportion-
ate travel burden. Many studies have so far established that
transport costs have serious implications for the accessibil-
ity of health care for the people in need [29–31]. An inverse
correlation between medical tourism travel barriers and
Table 6 Catastrophic health expenditure by type of finance, residential area, household size and household income of the patient
Households with health
spending <10 % of total
monthly expenditures
Households with health
spending >10 % of total
monthly expenditures
Total P value
N (%) N (%) N
Total 465 (57.1) 350 (42.9) 815
Type of finance 0.7
Government subsidized 199 (57.8) 145 (42.2) 344
Private finance 266 (56.5) 205 (43.5) 471
Region of residence <0.001
North 142 (58) 103 (42) 245
Central 247 (67.5) 119 (32.5) 366
South 76 (37.3) 128 (62.7) 204
Household size 0.4
Small (<5 members) 273 (57.1) 205 (42.9) 478
Medium (6–10 members) 147 (59) 102 (41) 249
Large (>10 members) 45 (51.1) 43 (48.9) 88
Household income 0.1
Poorest 20 % 86 (50) 86 (50) 172
2nd quintile 87 (56.5) 67 (43.5) 154
3rd quintile 127 (55.9) 100 (44.1) 227
4th quintile 84 (61.3) 53 (38.7) 137
Richest 20 % 81 (64.8) 44 (35.2) 125
Table 7 Economic cost of medical treatment overseas
Median per capita cost per visit (IQR) $ Est no of medical visits 2013 Annual cost per year (ase) $ % of GDP 2013 (ase)
(a) (b) (c) = (a × b)
Government subsidized (n = 344)
medical travelers 1905.08 (1254.4,3554.4) b3546 6,755,426 (851,408.3) 0.47 (0.11)
caretakers (mean = 2.3) 965.25 (679.8,1330.5) 8156 7,872,579 (387,083.3) 0.55 (0.08)
Private funded (n = 471)
medical travelers 1147.33 (709.6,1783) 15462 17,740,068 (1,595,637) 1.24 (0.08)
caretakers (mean = 3.3) 716.21 (470.6,1023) 51026 36,544,821 (1,656,017) 2.55 (0.07)
Productivity loss (n = 815) 0 (0,156.5) 0 (57.23) 0 (0)
Total 78190 68,912,894 (5,586,963) 4.81 (0.07)
(a) Costs from Study results, (b) population estimates from secondary data and study results, (c) extrapolations using (a) and (b)
GDP 2013 = $ 1,431 m, bnumber of visits subsidized by UC program, aBootstrap estimations
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willingness to use medical travel has also been identified
(correlation coefficient = −0.320, p < 0.001) [32]. If purchase
of overseas treatment is to be continued, a mechanism to
reduce travel costs for medical travelers is needed.
Medical costs were found to be the second major ex-
pense in a medical travel episode and medical costs for
privately funded patients were half that of the subsidized
patients. The comparatively higher medical costs of gov-
ernment subsidized patients in this study may be partly
due to targeting of the sick and old and partly due to in-
efficiencies in purchasing. The use of government to gov-
ernment bilateral diplomacy by the UK [33], strategic
purchasing methods [34], foreign direct investments in
Cambodia, Laos and Vietnam [35], telemedicine in Bhutan
[36] and technology assessments by Taiwan [37] are a few
of the strategies that have been used to contain costs in the
publicly funded health systems.
This study revealed that households bear a heavy bur-
den of MTO. 43 % of the households where medical
travelers lived experienced catastrophic health expend-
iture. Catastrophic spending was highest among travelers
from the Southern region where the proportion of trav-
elers who accessed public subsidy for MTO was lowest.
There have been no previous studies that measured cata-
strophic health spending due to treatment overseas. The
geographical disparity in catastrophic health spending
suggests a regional imbalance in access to public funds.
The association between public financing of health care
and reduced incidence of catastrophic health spending
has been well established [24, 38, 39], and findings from
this study adds to this literature on the importance of
broadening access to public funds. When expanding
coverage against a backdrop of geographical inequality
and high catastrophic health spending, the disadvan-
taged groups seeking MTO and the high priority ser-
vices for MTO need to be identified and targeted [40].
Similar to the high annual spending on overseas treat-
ment observed from this study ($68.9 million per year),
Bangladeshi medical tourists spent US$30 million in
India alone during 1998, [41] while Nigerians spent
twenty billion US dollars per year on medical travel [42]
and UK patients spent $180 million in 2010 [21]. How-
ever, the large populations of these countries would yield
low economic impact to the country’s economy in contrast
to the $204 per capita estimated to be spent by Maldivians
on medical treatment overseas. Our estimation on annual
expenditure on MTO ($68.9 m) was similar to findings
from the survey on Maldivian travel abroad (MTA 2013)
which estimated $70 million as annual MTO expenditure
[13]. The slight difference is due to methodological differ-
ences. While the MTA was conducted at a single inter-
national airport for one week among all types of travelers,
our survey focused specifically on medical travelers from
three international airports over a period of five months.
Strengths and limitations
While this study covered the different types of costs
using a combination of data sources which give better
insight, the data were based on samples from only five
months and may have suffered from under reporting
due to recall errors. The study period was an intensely po-
liticized period with presidential and parliamentary elec-
tions. This may have led to under reporting of variables
such as productivity loss and over reporting of other vari-
ables such as hospitalization and travel expenses paid by
the government. Since data on private insurance support
was not collected, out-of-pocket expenditure might have
been exaggerated but private insurance coverage is not ex-
pected to be high in the Maldives. As this study had limited
data on the reasons people who paid privately chose to do
so, an in depth qualitative study could explore the reasons
for MTO in greater depth.
Conclusions
Medical treatment overseas represents a substantial
economic burden to the Maldives in terms of lost con-
sumer spending in the local economy and catastrophic
health spending by households. Unlike medical trav-
elers from high income countries, Maldivians sought
middle to high priority health services for which the
existing benefit package needs to be prioritized. The
medical cost of a subsidized traveler was comparatively
higher than that of a privately funded traveler suggest-
ing opportunities to minimize costs by increasing the
efficiency with which healthcare is purchased from
overseas health facilities. Geographical inequality in
access to public funds for MTO and the disproportion-
ate burden of travel cost in the home country borne by
MTO travelers from rural areas need to be addressed
in order to minimize the burden of MTO. While the
Maldivian UHC program is financed through the gov-
ernment budget, the outflow on MTO represents a
considerable diversion of public funds to overseas fa-
cilities. Increased investment to create more capacity
in the domestic health infrastructure either through
government, private or by foreign direct investment
can help divert the outflow on MTO.
What is already known on this topic
 Treatment overseas usually focuses on the term
‘medical tourism’ which targets people who willingly
travel in search of quality care or better prices.
 The magnitude, effects, attitudes and costs of
medical tourism have been documented, but mostly
among well-established health systems.
 Cost estimations and cost comparisons of treatment
procedures in destination countries showed high
levels of economic burden to source countries.
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Focus is however mostly on the supply side of the
industry.
What this study adds
 The focus of this study is travelers having limited
choice in their home country because tertiary care is
neither available nor of good quality
 It demonstrates that MTO has a negative financial
impact at the household level and on the economy
in resource constrained health systems.
 It gives the demand side perspective of MTO.
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